Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1

Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jei Ha Lee, Soo Im Choi, Rae Kwon Kim, Eun Wie Cho, In Gyu Kim
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0ef08a7a1b0645949972a3ac06bfbd68
record_format dspace
spelling oai:doaj.org-article:0ef08a7a1b0645949972a3ac06bfbd682021-12-02T16:08:02ZTescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH110.1038/s41598-018-29142-x2045-2322https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd682018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29142-xhttps://doaj.org/toc/2045-2322Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties, consequently enhancing the cellular resistance to γ-radiation. TESC expression and the phosphorylation (consequent activation) of signal transducer and activator of transcription 3 (STAT3) were upregulated in CSC-like ALDH1high cells than in ALDH1low cells sorted from A549 NSCLC cells. Knockdown of TESC suppressed CSC-like properties as well as STAT3 activation through inhibition of insulin-like growth factor 1 receptor (IGF1R), a major signaling pathway of lung cancer stem cells. TESC activated IGF1R by the direct recruitment of proto-oncogene tyrosine kinase c-Src (c-Src) to IGF1Rβ complex. Treatment of IGF1R inhibitor, AG1024, also suppressed c-Src activation, implicating that TESC mediates the mutual activation of c-Src and IGF1R. STAT3 activation by TESC/c-Src/IGF1R signaling pathway subsequently upregulated ALDH1 expression, which enhanced EMT-associated CSC-like properties. Chromatin immunoprecipitation and luciferase assay demonstrated that STAT3 is a potential transcription activator of ALDH1 isozymes. Ultimately, targeting TESC can be a potential strategy to overcome therapeutic resistance in NSCLC caused by augmented EMT and self-renewal capacity.Jei Ha LeeSoo Im ChoiRae Kwon KimEun Wie ChoIn Gyu KimNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jei Ha Lee
Soo Im Choi
Rae Kwon Kim
Eun Wie Cho
In Gyu Kim
Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
description Abstract Tescalcin (TESC; also known as calcineurin B homologous protein 3, CHP3) has recently reported as a regulator of cancer progression. Here, we showed that the elevation of TESC in non-small cell lung cancer (NSCLC) intensifies epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) properties, consequently enhancing the cellular resistance to γ-radiation. TESC expression and the phosphorylation (consequent activation) of signal transducer and activator of transcription 3 (STAT3) were upregulated in CSC-like ALDH1high cells than in ALDH1low cells sorted from A549 NSCLC cells. Knockdown of TESC suppressed CSC-like properties as well as STAT3 activation through inhibition of insulin-like growth factor 1 receptor (IGF1R), a major signaling pathway of lung cancer stem cells. TESC activated IGF1R by the direct recruitment of proto-oncogene tyrosine kinase c-Src (c-Src) to IGF1Rβ complex. Treatment of IGF1R inhibitor, AG1024, also suppressed c-Src activation, implicating that TESC mediates the mutual activation of c-Src and IGF1R. STAT3 activation by TESC/c-Src/IGF1R signaling pathway subsequently upregulated ALDH1 expression, which enhanced EMT-associated CSC-like properties. Chromatin immunoprecipitation and luciferase assay demonstrated that STAT3 is a potential transcription activator of ALDH1 isozymes. Ultimately, targeting TESC can be a potential strategy to overcome therapeutic resistance in NSCLC caused by augmented EMT and self-renewal capacity.
format article
author Jei Ha Lee
Soo Im Choi
Rae Kwon Kim
Eun Wie Cho
In Gyu Kim
author_facet Jei Ha Lee
Soo Im Choi
Rae Kwon Kim
Eun Wie Cho
In Gyu Kim
author_sort Jei Ha Lee
title Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
title_short Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
title_full Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
title_fullStr Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
title_full_unstemmed Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1
title_sort tescalcin/c-src/igf1rβ-mediated stat3 activation enhances cancer stemness and radioresistant properties through aldh1
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/0ef08a7a1b0645949972a3ac06bfbd68
work_keys_str_mv AT jeihalee tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1
AT sooimchoi tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1
AT raekwonkim tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1
AT eunwiecho tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1
AT ingyukim tescalcincsrcigf1rbmediatedstat3activationenhancescancerstemnessandradioresistantpropertiesthroughaldh1
_version_ 1718384638269849600